Adverse Reactions to Ginkgo biloba Medicinal Products Released in European Countries

Phytother Res. 2025 May;39(5):2197-2201. doi: 10.1002/ptr.8475. Epub 2025 Mar 18.
No abstract available

Keywords: Ginkgo biloba; EudraVigilance; adverse events; adverse reactions; disproportionality analysis; herbal medicinal products; pharmacovigilance; real‐world data; reporting odds ratio.

Publication types

  • Letter